Serum malondialdehyde levels in Toxoplasma seropositive patients

Annals of Saudi Medicine

Volumn 23, Issue 6, 2003, Pages 413-415

  Yazar, Süleyman ^a   Kilic, Eser ^a   Saraymen, Recep ^a   Sahin, Izzet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SEROLOGY; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0348161534     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.413     Document Type: Article

References (14)

1. Montaya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;15:73-82.
2. Suzuki Y. Host resistance in the brain against Toxoplasma gondii. J Infect Dis.2002; 15:58-65.
3. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217-1258.
4. Deorari AK, Broor S, Maitreyi RS, Agarwal D, Kumar H, Paul VK, Singh M. Incidence, clinical spectrum, and outcome of intrauterine infections in neonates. J Trop Ped. 2000;46:155-159.
5. Smith JL. Foodborne infections during pregnancy. J Food Protect. 1999;62:818-829.
6. Jareno EJ, Bosch-Morell F, Fernandez-Delgado R, Donat J, Romero FJ. Serum malondialdehyde in HIV-seropositive children negatively correlates with CD4+ lymphocytes count. Biofactors. 1998; 8:129-132.
7. Sonnerborg A, Carlin G, Akerlund B, Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis. 1988;20:287-290.
8. Draper HH, Hadley M. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica. 1990; 20:901-907.
9. Nayak DU, Karmen C, Frishman WH, Vakili BA. Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease. Heart Dis.2001;3:28-45.
10. Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106:1229-1234.
11. Stocks J, Dormandy TL. The autoxidation of human red cell. Lipids induced by hydrogen peroxide. Br J Haematol. 1971;20: 95-111.
12. Jain SK. Evidence for membrane lipid peroxidation during the invivo aging of human erythrocytes. Biochem Biophys Acta. 1998; 937:205-210.
13. Storts RW. Central nervous system. In: Carlton WW, McGavin MD, eds. Thomson's special veterinary pathology. New York: Mosby Press;1995:332-392.
14. Frenkel JK, Dubey JP. Toxoplasmosis and its prevention in cats and man. J Infect Dis.1972;126:664-673.